Global Newcastle Disease Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.
Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.
The classification of Newcastle Disease Vaccine includes Live Vaccines and Killed Vaccines. The proportion of Killed Vaccines in 2016 is about 77.1%, These vaccines are made with virus that is alive and able to infect cells. Strains of virus of low or moderate virulence are used. They mimic natural infection and induce all three immune responses. And the proportion of Live Vaccines in 2016 is about 22.9%.
Newcastle Disease Vaccine is application in Chicken, Duck & Goose and others. The most of Newcastle Disease Vaccine is used in Chicken, and the market share in 2016 is about 87.5%.
Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can causes devastating losses in both commercial and village chickens. So Newcastle Disease Vaccine is necessary for farms with Chicken, Duck & Goose, etc.
Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology, etc. are the leader of this industry. With the development of society and the changing of consumer demand, the Newcastle Disease Vaccine industry will be more and more popular in the future.

Market Analysis and Insights: Global Newcastle Disease Vaccine Market
In 2019, the global Newcastle Disease Vaccine market size was US$ 296.7 million and it is expected to reach US$ 378.5 million by the end of 2026, with a CAGR of 3.5% during 2021-2026.
Global Newcastle Disease Vaccine Scope and Market Size
Newcastle Disease Vaccine market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Newcastle Disease Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

Segment by Type, the Newcastle Disease Vaccine market is segmented into
Live Vaccines
Killed Vaccines

Segment by Application, the Newcastle Disease Vaccine market is segmented into
Chicken
Duck & Goose
Other

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape

and Newcastle Disease Vaccine Market Share Analysis
Newcastle Disease Vaccine market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Newcastle Disease Vaccine product introduction, recent developments, Newcastle Disease Vaccine sales by region, type, application and by sales channel.

The major companies include:
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo